CORNERCAP INVESTMENT COUNSEL INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 167 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CORNERCAP INVESTMENT COUNSEL INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$1,321,238
+14.9%
35,233
-14.2%
0.23%
+17.1%
Q4 2022$1,150,109
-0.3%
41,0460.0%0.20%
-8.7%
Q3 2022$1,153,000
+10.1%
41,046
+36.3%
0.22%
+19.8%
Q2 2022$1,047,000
-37.9%
30,107
-35.9%
0.18%
-3.7%
Q1 2022$1,687,000
+22.8%
46,995
-20.3%
0.19%
-5.0%
Q4 2021$1,374,000
+25.4%
58,975
+2.3%
0.20%
+59.2%
Q3 2021$1,096,000
-16.3%
57,649
-11.2%
0.12%
-13.8%
Q2 2021$1,309,000
+30.5%
64,924
+18.6%
0.14%
+29.5%
Q1 2021$1,003,000
+157.2%
54,751
+163.4%
0.11%
+103.6%
Q3 2020$390,00020,7900.06%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders